Skip to main content
Earnings Labs
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. (MCRB)

NASDAQ·Healthcare·Biotechnology

$6.30

+5.44%

Mkt Cap $83.09M

Analyst Ratings

No recent rating data.

Price Target (1 analysts)

$1.25

Range $1.25$1.25

Implied Upside

-80.1%

Consensus $1.25 vs current $6.30